Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Funda Meric-Bernstam

Showing results (161-170 of 685) with videos related to

Pageof 69
Sort By:
Radiation Oncology (London, England)|January 15, 2013
Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomyHeath D Skinner, Eric A Strom, Sabin B Motwani, et al.
Annals of Surgical Oncology|September 19, 2013
Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patientsAbigail S Caudle, Min Yi, Karen E Hoffman, et al.
Breast Cancer Research and Treatment|March 1, 2017
Identification of frequent somatic mutations in inflammatory breast cancerNaoko Matsuda, Bora Lim, Ying Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2017
Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue SarcomaVivek Subbiah, Christian Meyer, Ralph Zinner, et al.
Biomedical Optics Express|January 28, 2014
Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agentsFunda Meric-Bernstam, John C Rasmussen, Savitri Krishnamurthy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcomeChafika Mazouni, Florentia Peintinger, Shu Wan-Kau, et al.
Cancer Medicine|November 29, 2021
Phase 1 trial of ADI-PEG 20 and liposomal doxorubicin in patients with metastatic solid tumorsShuyang Yao, Filip Janku, Kimberly Koenig, et al.
International Journal of Medical Informatics|February 17, 2016
Patient knowledge and information-seeking about personalized cancer therapyDeevakar Rogith, Rafeek A Yusuf, Shelley R Hovick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2012
Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excisionMin Yi, Funda Meric-Bernstam, Henry M Kuerer, et al.
Discovery Medicine|February 19, 2014
Implementation of biomarker-driven cancer therapy: existing tools and remaining gapsAnn M Bailey, Yong Mao, Jia Zeng, et al.
Pageof 69

Showing results (161-170 of 685) with videos related to

Sort By:
Pageof 69
Radiation Oncology (London, England)|January 15, 2013
Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomyHeath D Skinner, Eric A Strom, Sabin B Motwani, et al.
Annals of Surgical Oncology|September 19, 2013
Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patientsAbigail S Caudle, Min Yi, Karen E Hoffman, et al.
Breast Cancer Research and Treatment|March 1, 2017
Identification of frequent somatic mutations in inflammatory breast cancerNaoko Matsuda, Bora Lim, Ying Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2017
Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue SarcomaVivek Subbiah, Christian Meyer, Ralph Zinner, et al.
Biomedical Optics Express|January 28, 2014
Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agentsFunda Meric-Bernstam, John C Rasmussen, Savitri Krishnamurthy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcomeChafika Mazouni, Florentia Peintinger, Shu Wan-Kau, et al.
Cancer Medicine|November 29, 2021
Phase 1 trial of ADI-PEG 20 and liposomal doxorubicin in patients with metastatic solid tumorsShuyang Yao, Filip Janku, Kimberly Koenig, et al.
International Journal of Medical Informatics|February 17, 2016
Patient knowledge and information-seeking about personalized cancer therapyDeevakar Rogith, Rafeek A Yusuf, Shelley R Hovick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2012
Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excisionMin Yi, Funda Meric-Bernstam, Henry M Kuerer, et al.
Discovery Medicine|February 19, 2014
Implementation of biomarker-driven cancer therapy: existing tools and remaining gapsAnn M Bailey, Yong Mao, Jia Zeng, et al.
Pageof 69